368 related articles for article (PubMed ID: 26223461)
21. The pathogenesis of classical Hodgkin's lymphoma: what can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells?
Janz M; Mathas S
Haematologica; 2008 Sep; 93(9):1292-5. PubMed ID: 18757849
[No Abstract] [Full Text] [Related]
22. Nivolumab in the Treatment of Hodgkin Lymphoma.
Ansell SM
Clin Cancer Res; 2017 Apr; 23(7):1623-1626. PubMed ID: 27881581
[TBL] [Abstract][Full Text] [Related]
23. Targeting Immune System Alterations in Hodgkin Lymphoma.
Grover NS; Savoldo B
Curr Hematol Malig Rep; 2017 Aug; 12(4):358-369. PubMed ID: 28780614
[TBL] [Abstract][Full Text] [Related]
24. Reed-Sternberg-Like Cells in Non-Hodgkin Lymphomas.
Gomez-Gelvez JC; Smith LB
Arch Pathol Lab Med; 2015 Oct; 139(10):1205-10. PubMed ID: 26414463
[TBL] [Abstract][Full Text] [Related]
25. Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed-Sternberg cells.
Bai M; Tsanou E; Agnantis NJ; Kamina S; Grepi C; Stefanaki K; Rontogianni D; Galani V; Kanavaros P
Mod Pathol; 2004 Nov; 17(11):1338-45. PubMed ID: 15354186
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's lymphoma: molecular targets and novel treatment strategies.
Yazbeck V; Georgakis GV; Wedgwood A; Younes A
Future Oncol; 2006 Aug; 2(4):533-51. PubMed ID: 16922620
[TBL] [Abstract][Full Text] [Related]
27. Checkpoint inhibitors in Hodgkin's lymphoma.
Jezeršek Novaković B
Eur J Haematol; 2016 Apr; 96(4):335-43. PubMed ID: 26560962
[TBL] [Abstract][Full Text] [Related]
28. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.
Bräuninger A; Hansmann ML; Strickler JG; Dummer R; Burg G; Rajewsky K; Küppers R
N Engl J Med; 1999 Apr; 340(16):1239-47. PubMed ID: 10210707
[TBL] [Abstract][Full Text] [Related]
29. New drugs and targeted treatments in Hodgkin's lymphoma.
Provencio M; Sánchez A; Sánchez-Beato M
Cancer Treat Rev; 2014 Apr; 40(3):457-64. PubMed ID: 24095205
[TBL] [Abstract][Full Text] [Related]
30. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
[TBL] [Abstract][Full Text] [Related]
31. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
32. Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components.
Greaves WO; Bueso-Ramos C; Fayad L
J Clin Oncol; 2011 Feb; 29(4):e76-8. PubMed ID: 21041711
[No Abstract] [Full Text] [Related]
33. Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease.
Newcom SR; Gu L
J Clin Pathol; 1995 Feb; 48(2):160-3. PubMed ID: 7745117
[TBL] [Abstract][Full Text] [Related]
34. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
[TBL] [Abstract][Full Text] [Related]
35. Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.
Dutton A; Burns AT; Young LS; Murray PG
Expert Rev Anticancer Ther; 2006 Jun; 6(6):911-9. PubMed ID: 16761935
[TBL] [Abstract][Full Text] [Related]
36. DNA Superresolution Structure of Reed-Sternberg Cells Differs Between Long-Lasting Remission Versus Relapsing Hodgkin's Lymphoma Patients.
Righolt CH; Knecht H; Mai S
J Cell Biochem; 2016 Jul; 117(7):1633-7. PubMed ID: 26639515
[TBL] [Abstract][Full Text] [Related]
37. Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge.
Kourie HR; Tabchi S; Kattan J
Future Oncol; 2016 Jun; 12(12):1435-7. PubMed ID: 27117227
[No Abstract] [Full Text] [Related]
38. The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC.
Hnátková M; Mociková H; Trnený M; Zivný J
Prague Med Rep; 2009; 110(1):35-41. PubMed ID: 19591376
[TBL] [Abstract][Full Text] [Related]
39. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
40. Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
Yurchenko M; Sidorenko SP
Exp Oncol; 2010 Dec; 32(4):214-23. PubMed ID: 21270747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]